“Patients are waiting for therapeutic improvement and asking us – while we have good technologies – are we really bringing them the best new drugs? And if we look hard in the mirror the fact is that we are not using technology optimally”, said Dr. Denis Lacombe, EORTC Director. “There needs to be more collaboration, new models…and that means we have to think outside the box.”
Related News
Does radiofrequency ablation of unresectable colorectal liver metastases prolong long-term survival?
23 Mar 2017
Does radiofrequency ablation of unresectable colorectal liver metastases prolong long-term survival?
23 Mar 2017
In memory of Professor Franck Bonnetain
6 Jun 2017